{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:52:45Z","timestamp":1789811565318,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Netherlands Ministry of Health Welfare and Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.mucimm.2024.03.008","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T17:07:21Z","timestamp":1711559241000},"page":"554-564","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands"],"prefix":"10.1016","volume":"17","author":[{"given":"Marije K.","family":"Verheul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8714-4784","authenticated-orcid":false,"given":"Joanna","family":"Kaczorowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marloes I.","family":"Hofstee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3180-1807","authenticated-orcid":false,"given":"Rutger M.","family":"Schepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4890-0940","authenticated-orcid":false,"given":"Gaby P.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewi","family":"Wessels Beljaars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9902-5790","authenticated-orcid":false,"given":"Marjan","family":"Kuijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Schuin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2686-4594","authenticated-orcid":false,"given":"Irene","family":"Middelhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheyenne C.E.","family":"van Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.A.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9124-5836","authenticated-orcid":false,"given":"M. Alina","family":"Nicolaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester E.","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"van Binnendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona R.M.","family":"van der Klis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-6315","authenticated-orcid":false,"given":"Gerco","family":"den Hartog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mucimm.2024.03.008_b0005","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3390\/vaccines10030350","article-title":"Efficacy and effectiveness of SARS-CoV-2 vaccines: a systematic review and meta-analysis","volume":"10","author":"Ghazy","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mucimm.2024.03.008_b0010","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41591-022-01699-1","article-title":"Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England","volume":"28","author":"Andrews","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.mucimm.2024.03.008_b0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(23)00001-4","article-title":"Tracking immune correlates of protection for emerging SARS-CoV-2 variants","volume":"23","author":"Nilles","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.03.008_b0020","doi-asserted-by":"crossref","first-page":"19858","DOI":"10.1038\/s41598-022-22552-y","article-title":"Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after Mrna or vector-based COVID-19 vaccinations","volume":"12","author":"Jacobsen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mucimm.2024.03.008_b0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41385-020-00359-2","article-title":"The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection","volume":"14","author":"Gallo","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2024.03.008_b0030","doi-asserted-by":"crossref","first-page":"eadd4853","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 after Mrna vaccination","volume":"7","author":"Tang","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.mucimm.2024.03.008_b0035","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1038\/s41467-022-32389-8","article-title":"SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals","volume":"13","author":"Sano","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mucimm.2024.03.008_b0040","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/cid\/ciac378","article-title":"A single dose of BNT162b2 messenger RNA vaccine induces airway immunity in severe acute respiratory syndrome coronavirus 2 naive and recovered coronavirus disease 2019 subjects","volume":"75","author":"Martinuzzi","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.03.008_b0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1473-3099(22)00834-9","article-title":"7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection","volume":"23","author":"Marking","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.03.008_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104248","article-title":"Protection against SARS-CoV-2 transmission by a parenteral prime-intranasal boost vaccine strategy","volume":"84","author":"Christensen","year":"2022","journal-title":"Ebiomedicine."},{"key":"10.1016\/j.mucimm.2024.03.008_b0055","doi-asserted-by":"crossref","first-page":"eabo2523","DOI":"10.1126\/science.abo2523","article-title":"Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses","volume":"378","author":"Mao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.mucimm.2024.03.008_b0060","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1126\/science.abj2258","article-title":"Hybrid immunity","volume":"372","author":"Crotty","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.mucimm.2024.03.008_b0065","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3390\/vaccines10091480","article-title":"Reduced antibody acquisition with increasing age following vaccination with BNT162b2: results from two longitudinal cohort studies in the Netherlands","volume":"10","author":"van den Hoogen","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mucimm.2024.03.008_b0070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.7.4.467","article-title":"Age-related decline in immunity: implications for vaccine responsiveness","volume":"7","author":"Kumar","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.mucimm.2024.03.008_b0075","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/cid\/ciac934","article-title":"Comparison of levels of nasal, salivary, and plasma antibody to severe acute respiratory syndrome coronavirus 2 during natural infection and after vaccination","volume":"76","author":"Cohen","year":"2023","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.03.008_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.953949","article-title":"Mrna vaccination drives differential mucosal neutralizing antibody profiles in na\u00efve and SARS-CoV-2 previously-infected individuals","volume":"13","author":"Longet","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2024.03.008_b0085","doi-asserted-by":"crossref","first-page":"24448","DOI":"10.1038\/s41598-021-03931-3","article-title":"Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 Mrna vaccination","volume":"11","author":"Mades","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mucimm.2024.03.008_b0090","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.4049\/jimmunol.2100990","article-title":"Cutting Edge: serum but not mucosal antibody responses are associated with pre-existing SARS-CoV-2 spike cross-reactive CD4+ T cells following BNT162b2 vaccination in the elderly","volume":"208","author":"Meyer-Arndt","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2024.03.008_b0095","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1126\/science.abg9175","article-title":"Mrna vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection","volume":"372","author":"Stamatatos","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.mucimm.2024.03.008_b0100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.mucimm.2024.03.008_b0105","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMc2209651","article-title":"Anti-spike mucosal IgA protection against SARS-CoV-2 omicron infection","volume":"387","author":"Havervall","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mucimm.2024.03.008_b0110","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1038\/s41467-023-40195-z","article-title":"Effects of COVID-19 vaccination and previous infection on Omicron SARS-CoV-2 infection and relation with serology","volume":"14","author":"de Gier","year":"2023","journal-title":"Nature Communications."},{"key":"10.1016\/j.mucimm.2024.03.008_b0115","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s41467-023-37559-w","article-title":"Limited induction of polyfunctional lung-resident memory T cells against SARS-CoV-2 by Mrna vaccination compared to infection","volume":"14","author":"Pieren","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mucimm.2024.03.008_b0120","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.vaccine.2022.03.009","article-title":"Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: a complementary tool to detect breakthrough infections after COVID-19 vaccination?","volume":"40","author":"van den Hoogen","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.mucimm.2024.03.008_b0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jech-2020-215678","article-title":"Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave","volume":"75","author":"Vos","year":"2021","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.mucimm.2024.03.008_b0130","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1093\/cid\/ciab264","article-title":"Associations between measures of social distancing and severe acute respiratory syndrome coronavirus 2 seropositivity: a nationwide population-based study in the Netherlands","volume":"73","author":"Vos","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.03.008_b0135","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/infdis\/jiaa479","article-title":"SARS-CoV-2-specific antibody detection for seroepidemiology: a multiplex analysis approach accounting for accurate seroprevalence","volume":"222","author":"den Hartog","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.03.008_b0140","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/cid\/ciab172","article-title":"Persistence of antibodies to severe acute respiratory syndrome coronavirus 2 in relation to symptoms in a nationwide prospective study","volume":"73","author":"den Hartog","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.mucimm.2024.03.008_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v032.i06","article-title":"mixtools: an R package for Analyzing Mixture Models","volume":"32","author":"Benaglia","year":"2009","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.mucimm.2024.03.008_b0150","doi-asserted-by":"crossref","first-page":"eabj1750","DOI":"10.1126\/sciimmunol.abj1750","article-title":"SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees","volume":"6","author":"Geers","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.mucimm.2024.03.008_b0155","doi-asserted-by":"crossref","unstructured":"Wickam, H. Ggplot2: elegant graphics for data analysis. Springer-Verlag [Accessed March 2016]. 16 (2021). https:\/\/doi.org\/10.3389\/fimmu.2022.953949.","DOI":"10.3389\/fimmu.2022.953949"},{"key":"10.1016\/j.mucimm.2024.03.008_b0160","doi-asserted-by":"crossref","unstructured":"L\u00fcdecke, D. SjPlot: data visualization for statistics in social science. R package version 2.8. 10. (R Foundation for Statistical Computing) (2021). https:\/\/doi.org\/10.1038\/s41598-021-03931-3.","DOI":"10.1038\/s41598-021-03931-3"},{"key":"10.1016\/j.mucimm.2024.03.008_b0165","doi-asserted-by":"crossref","unstructured":"Kassambara, A. Ggpubr:\u201cggplot2\u201d based publication ready plots. R package version 04 0. 438 (2020). https:\/\/doi.org\/10.1126\/sciimmunol.add4853.","DOI":"10.1126\/sciimmunol.add4853"},{"key":"10.1016\/j.mucimm.2024.03.008_b0170","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1080\/01621459.2016.1180986","article-title":"Smoothing parameter and model selection for general smooth models","volume":"111","author":"Wood","year":"2016","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.mucimm.2024.03.008_b0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1198\/000313006X118430","article-title":"A Lego system for conditional inference","volume":"60","author":"Hothorn","year":"2006","journal-title":"Am. Stat."},{"key":"10.1016\/j.mucimm.2024.03.008_b0180","doi-asserted-by":"crossref","unstructured":"Kassambara, A. Rstatix: pipe-friendly framework for basic statistical tests. R package version 06 0 (2020). https:\/\/doi.org\/10.4049\/jimmunol.2100990.","DOI":"10.32614\/CRAN.package.rstatix"},{"key":"10.1016\/j.mucimm.2024.03.008_b0185","first-page":"18","article-title":"Classification and regression by randomForest","volume":"2","author":"Liaw","year":"2002","journal-title":"R News."},{"key":"10.1016\/j.mucimm.2024.03.008_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2105-12-77","article-title":"Proceedings of the: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf."}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021924000278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021924000278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T22:13:43Z","timestamp":1744496023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021924000278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1933021924000278"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2024.03.008","relation":{},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2024.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}]}}